Benzinga | Jul 30, 2021 07:41AM EDT

Wells Fargo Maintains Equal-Weight on Edwards Lifesciences, Raises Price Target to $115

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Equal-Weight and raises the price target from $93 to $115.